Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma, Cutaneous Malignant × Dacarbazine × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 17 Melanoma 7 Sarcoma 3 Neoplasms 3 Lymphoma 3 Uveal Melanoma 2 Leiomyosarcoma 2 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Melanoma, Cutaneous Malignant 1 Lung Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Kidney Neoplasms 1 Immunotherapy 1 Hyperthermia 1 Colonic Neoplasms 1 Breast Neoplasms 1 Advanced Melanoma 1

Interventions

pembrolizumab 3 relatlimab 1 lifileucel 1 dabrafenib 1 Temozolomide 1 Paclitaxel 1 Opdualag 1 Nivolumab 1 Ipilimumab 1 Electrochemotherapy 1 Dacarbazine 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06743126 2026-04-21

SUPRAME

Immatics US, Inc.

Phase 3 Recruiting

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡